Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
التنسيق: Journal article
منشور في: Nature Publishing Group 2017

مواد مشابهة